Next review date: 2017

This guideline updates and replaces NICE guideline CG48 (published May 2007).

This guideline was previously called MI - secondary prevention: secondary prevention in primary and secondary care for patients following a myocardial infarction.

Recommendation 1.3 in NICE technology appraisal 80 (published in July 2004) has been updated by recommendation 1.3.18 in CG172

It offers evidence-based advice on secondary prevention for patients in primary and secondary care after an MI. New and updated recommendations on cardiac rehabilitation, lifestyle changes, drug therapy and communication of diagnosis and advice were included in 2013.

Your responsibility

The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The application of the recommendations in this guideline is not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.

Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties.

  • National Institute for Health and Care Excellence (NICE) accreditation logo